Research Article
Safety Profile of Liver FibroScan in Patients with Cardiac Pacemakers or Implantable Cardioverter-Defibrillators
Table 1
Baseline characteristics.
| | Characteristics | All subjects () |
| | Demographic | | | Age, years | 80 (71–86) | | Male sex | 66 (58%) | | Body mass index, kg/m2 | 27 (24–30) | | Ethnicity, Caucasian | 109 (96%) | | Known cirrhotic | 1 (1%) | | Cardiac device history | | | Pacemaker | 99 (88%) | | Implantable cardioverter-defibrillators | 14 (12%) | | Years after implantation | 4 (2–7) | | Pacer-dependent | 53 (47%) | | Right pectoral implantation site | 1 (1%) | | Cardiac device indication | | | Sinus node dysfunction | 55 (49%) | | Acquired AV block | 36 (32%) | | DCM or VT/VF | 12 (11%) |
|
|
Data presented as (%) or median (interquartile range). AV: atrioventricular node dysfunction. DCM: dilated cardiomyopathy. VT: ventricular tachycardia. VF: ventricular fibrillation.
|
